Since inflammation-driven immune escape and fibrosis (ECM stiffening) are key processes that drive glioblastoma pathogenesis, the high expression of SUMO2 in inflammation-promoting macrophages and stromal cells indicates that it may be crucial in their maintenance [69, 70]. This evidence concerns the gene SUMO2 and glioblastoma.